Komori
Japan Animal Referral Medical Center (6039) · InitiativeAdvanced

Shareholder Returns and Improved Capital Efficiency Through Share Repurchases

First written in FY2020. 13 of 14 entries say "Advanced", first in FY2021-Q1. Latest entry: FY2025-H1.

14entries
5years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseAdvancedFY2021-Q1 – FY2025-H12020: 320202021: 420212022: 320222023: 120232024: 32024
Same theme, other companies
Flexible Shareholder Returns and Capital Policy Through Board AuthorityA theme 552 companies write about · 0 as a headwind · 553 as a tailwind
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 199 companies compared. The sentences above are computed from all 199.Comparing 200 of the theme's 553 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2025-H1AdvancedAnnual report

    「This was mainly attributable to a ¥164.895 million decrease from the acquisition of treasury shares, a ¥25.188 million increase from the disposal of treasury shares, a ¥53.865 million decrease from dividend payments, and a ¥242.840 million increase from interim net income attributable to owners of the parent.」

    During the interim period, the company recorded a ¥164.895 million decrease in net assets from the acquisition of treasury shares and a ¥25.188 million increase from their disposal, updating the status of treasury share acquisitions and disposals.
  2. FY2024AdvancedAnnual report

    「During the fiscal year, the company acquired 68,500 treasury shares for ¥120,380,500. It also disposed of 14,500 treasury shares upon exercise of share options.」

    During the consolidated fiscal year, the company recorded the acquisition of 121,300 treasury shares for ¥328.616 million, marking further progress in treasury share acquisitions and disposals.
  3. FY2024-Q3AdvancedAnnual report

    「This was mainly attributable to a ¥85.900 million decrease from the acquisition of treasury shares, a ¥45.584 million increase from the disposal of treasury shares, and a ¥220.611 million increase from quarterly net income attributable to owners of the parent.」

    During the cumulative third quarter, treasury shares were acquired and disposed of, and the company disclosed the impact on net assets as a ¥85.900 million treasury share acquisition and a ¥45.584 million treasury share disposal.
  4. FY2024-Q2AdvancedAnnual report

    「Proceeds from the disposal of treasury shares ¥3.000 million」

    During the cumulative second quarter, the company recorded ¥3.000 million of proceeds from the disposal of treasury shares.
  5. FY2023-Q2AdvancedAnnual report

    「Cash paid for the acquisition of treasury shares - Proceeds from the disposal of treasury shares ¥1.000 million」

    During the cumulative second quarter, the company made no cash payment for the acquisition of treasury shares and recorded ¥1.000 million of proceeds from the disposal of treasury shares.
  6. FY2022AdvancedAnnual report

    「During the fiscal year, the company acquired 68,500 treasury shares for ¥120,380,500. It also disposed of 14,500 treasury shares upon exercise of share options.」

    The treasury share acquisition based on the resolution adopted on 20 December 2021 progressed to 68,500 shares costing ¥120,380,500. The company also disposed of 14,500 treasury shares upon exercise of share options.
  7. FY2022-Q3AdvancedAnnual report

    「During the third quarter, the company acquired 5,000 treasury shares based on the resolution adopted at the Board of Directors meeting held on 20 December 2021. It also disposed of 3,000 shares upon exercise of share options. As a result, the number of treasury shares stood at 55,100 at the end of the third quarter.」

    Based on the resolution adopted on 20 December 2021, the company acquired 5,000 treasury shares and disposed of 3,000 shares upon exercise of share options. The number of treasury shares at period-end was 55,100.
  8. FY2022-Q2AdvancedAnnual report

    「Cash paid for the acquisition of treasury shares △ ¥73 thousand Proceeds from the disposal of treasury shares ¥1.250 million」

    During the cumulative second quarter, the company recorded ¥73 thousand of cash paid for the acquisition of treasury shares and ¥1.250 million of proceeds from the disposal of treasury shares.
  9. FY2022-Q1AdvancedAnnual report

    「During the first quarter, the company acquired 39 shares in response to requests to purchase odd-lot shares. It also disposed of 500 treasury shares upon exercise of share options. As a result, the number of treasury shares stood at 55,100 at the end of the first quarter.」

    The company acquired 39 odd-lot treasury shares and disposed of 500 shares upon exercise of share options, leaving 55,100 treasury shares at period-end.
  10. FY2021AdvancedAnnual report

    「Based on the resolution adopted at the Board of Directors meeting held on 19 March 2020, the company acquired 91,400 treasury shares and acquired an additional 29 odd-lot shares during the cumulative third quarter, increasing treasury shares by ¥147.850 million (91,429 shares).」

    The company acquired a cumulative total of 91,429 treasury shares for ¥147.850 million, advancing its shareholder return and capital efficiency initiatives during the fiscal year.
  11. FY2021-Q3AdvancedAnnual report

    「Based on the resolution adopted at the Board of Directors meeting held on 19 March 2020, the company acquired 91,400 treasury shares, and acquired an additional 29 odd-lot shares during the cumulative third quarter, increasing treasury shares by ¥147.850 million (91,429 shares). During the cumulative third quarter, treasury shares decreased by ¥58.958 million (36,500 shares) through the disposal of 3,500 shares upon exercise of share options. As a result, treasury shares stood at ¥102.724 million (63,577 shares) at the end of the third quarter.」

    Following the acquisition of 91,429 treasury shares, 36,500 shares were disposed of upon exercise of share options, leaving 63,577 treasury shares at period-end. The status of treasury share acquisitions and disposals was updated.
  12. FY2021-Q2AdvancedAnnual report

    「During the cumulative second quarter, the company acquired treasury shares under the resolution adopted at the Board of Directors meeting held on 19 March 2020, increasing treasury shares by ¥147.700 million (91,400 shares). Treasury shares decreased by ¥53.303 million (33,000 shares) through the disposal of 8,000 shares upon exercise of share options and 25,000 shares disposed of as restricted stock compensation under the resolution adopted at the Board of Directors meeting held on 6 August 2020. As a result, treasury shares stood at ¥108.300 million (67,048 shares) at the end of the second quarter.」

    Following the treasury share acquisition, treasury shares were disposed of through the exercise of share options and restricted stock compensation, leaving 67,048 treasury shares at period-end.
  13. FY2021-Q1AdvancedAnnual report

    「Based on the resolution adopted at the Board of Directors meeting held on 19 March 2020, the company acquired 91,400 treasury shares. As a result, treasury shares increased by ¥147.770 million during the cumulative first quarter, bringing treasury shares to ¥161.603 million at the end of the first quarter.」

    Based on its treasury share acquisition policy, the company acquired 91,400 shares for ¥147.770 million, marking tangible progress in the treasury share acquisition program.
  14. FY2020First statedAnnual report

    「The company acquired treasury shares from March through May 2020.」

    The company conducted its first treasury share acquisition to return value to shareholders, improve capital efficiency and implement a flexible capital policy. The Board of Directors resolution set an upper limit of 100,000 shares and total acquisition costs of ¥180 million.
Moved together

"Providing State-of-the-Art Veterinary Care and Achieving Qualitative Growth" moved the same way as this thread, in the same document, in 13 of its 14 moves.

13119665★123456
  1. ★This thread
  2. 1Providing State-of-the-Art Veterinary Care and Achieving Qualitative Growth13×
  3. 2High Dependence on Interest-Bearing Debt and Interest Rate and Refinancing Risks11×
  4. 3Target to increase the number of first-time consultations as the most important management metric9×
  5. 4Expansion and strengthening of the affiliated-hospital network6×
  6. 5Consolidation through the relocation of CAMIC facilities and the introduction of high-performance MRI and CT systems6×
  7. 6Expansion of secondary-care facilities in major cities nationwide5×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Japan Animal Referral Medical Center yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Shareholder Returns and Improved Capital Efficiency Through Share Repurchases | Japan Animal Referral Medical Center Co.,Ltd. (6039) | Komori